State-of-the-art behavioral and pharmacological treatments for alcohol use disorderLara A. Ray, Karen Miotto, Spencer Bujarski et al.|The American Journal of Drug and Alcohol Abuse|2018Cited by 137
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical TrialLara A. Ray, Karen Miotto, Gang Li et al.|American Journal of Psychiatry|2021Cited by 37
Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokersDaniel Roche, Lara A. Ray, Spencer Bujarski et al.|Pharmacology Biochemistry and Behavior|2015Cited by 20
Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol cravingEmily E. Hartwell, Lara A. Ray, Spencer Bujarski et al.|Addictive Behaviors Reports|2019Cited by 18
Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized TrialLara A. Ray, Karen Miotto, ReJoyce Green et al.|Alcoholism Clinical and Experimental Research|2017Cited by 16